[{"address1": "5959 Horton Street", "address2": "7th Floor", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 871 4880", "website": "https://metagenomi.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Metagenomi Therapeutics, Inc. a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in EmeryVille, California.", "fullTimeEmployees": 124, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jian  Irish M.B.A., Ph.D.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 734626, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian Charles Thomas Ph.D.", "age": 56, "title": "Co-Founder & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 913299, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pamela M. Wapnick M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 581813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Knowles M.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Leonard", "title": "Senior Vice Pres\u00adi\u00addent of Tech\u00adni\u00adcal Devel\u00adop\u00adment & Oper\u00ada\u00adtions", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Brooks Ph.D.", "age": 59, "title": "Senior Vice President of Research", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Katalin  Kauser M.D., Ph.D.", "title": "Senior Vice Pres\u00adi\u00addent of Trans\u00adla\u00adtion\u00adal Biol\u00ado\u00adgy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.58, "open": 1.57, "dayLow": 1.525, "dayHigh": 1.5899, "regularMarketPreviousClose": 1.58, "regularMarketOpen": 1.57, "regularMarketDayLow": 1.525, "regularMarketDayHigh": 1.5899, "payoutRatio": 0.0, "forwardPE": -0.8438356, "volume": 185101, "regularMarketVolume": 185101, "averageVolume": 357972, "averageVolume10days": 251200, "averageDailyVolume10Day": 251200, "bid": 1.52, "ask": 1.56, "bidSize": 3, "askSize": 3, "marketCap": 57821996, "fiftyTwoWeekLow": 1.23, "fiftyTwoWeekHigh": 3.95, "allTimeHigh": 12.74, "allTimeLow": 1.23, "priceToSalesTrailing12Months": 1.870475, "fiftyDayAverage": 1.6847, "twoHundredDayAverage": 1.926, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -84629000, "profitMargins": -2.8705702, "floatShares": 27252934, "sharesOutstanding": 37546751, "sharesShort": 2358973, "sharesShortPriorMonth": 2045457, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.062800005, "heldPercentInsiders": 0.29292, "heldPercentInstitutions": 0.1731, "shortRatio": 7.33, "shortPercentOfFloat": 0.0862, "impliedSharesOutstanding": 37546751, "bookValue": 4.753, "priceToBook": 0.3240059, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -88738000, "trailingEps": -2.39, "forwardEps": -1.825, "enterpriseToRevenue": -2.738, "enterpriseToEbitda": 0.975, "52WeekChange": -0.38645416, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 1.54, "targetHighPrice": 12.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.33333, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 184114000, "totalCashPerShare": 4.904, "ebitda": -86791000, "totalDebt": 41663000, "quickRatio": 6.3, "currentRatio": 6.417, "totalRevenue": 30913000, "debtToEquity": 23.348, "revenuePerShare": 0.831, "returnOnAssets": -0.19023001, "returnOnEquity": -0.40872002, "grossProfits": -65183000, "freeCashflow": -55426124, "operatingCashflow": -91622000, "revenueGrowth": -0.248, "grossMargins": -2.1086, "ebitdaMargins": -2.80759, "operatingMargins": -2.6376002, "financialCurrency": "USD", "symbol": "MGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_633445224", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -2.5316505, "regularMarketPrice": 1.54, "epsTrailingTwelveMonths": -2.39, "epsForward": -1.825, "epsCurrentYear": -2.3375, "priceEpsCurrentYear": -0.6588235, "fiftyDayAverageChange": -0.14470005, "fiftyDayAverageChangePercent": -0.085890695, "twoHundredDayAverageChange": -0.38600004, "twoHundredDayAverageChangePercent": -0.20041539, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-02-09", "cryptoTradeable": false, "shortName": "Metagenomi Therapeutics, Inc.", "longName": "Metagenomi Therapeutics, Inc.", "fiftyTwoWeekLowChange": 0.30999994, "fiftyTwoWeekLowChangePercent": 0.25203246, "fiftyTwoWeekRange": "1.23 - 3.95", "fiftyTwoWeekHighChange": -2.41, "fiftyTwoWeekHighChangePercent": -0.6101266, "fiftyTwoWeekChangePercent": -38.645416, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755115200, "isEarningsDateEstimate": true, "averageDailyVolume3Month": 357972, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1707489000000, "postMarketChangePercent": -1.7532436, "postMarketPrice": 1.513, "postMarketChange": -0.02699995, "regularMarketChange": -0.04000008, "regularMarketDayRange": "1.525 - 1.5899", "fullExchangeName": "NasdaqGS", "corporateActions": [], "postMarketTime": 1769820426, "regularMarketTime": 1769806802, "displayName": "Metagenomi Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]